Molecular serum signature of treatment resistant depression (Q48051448)

8 February 2018

title

Molecular serum signature of treatment resistant depression (English)

1 reference

8 February 2018

author

Laura Große

4

1 reference

8 February 2018

Sabine Bahn

8

object named as

Sabine Bahn

1 reference

8 February 2018

Tillmann Ruland

1

1 reference

8 February 2018

Man K Chan

2

1 reference

8 February 2018

Pawel Stocki

3

1 reference

8 February 2018

Matthias Rothermundt

5

1 reference

8 February 2018

Jason D Cooper

6

1 reference

8 February 2018

Volker Arolt

7

1 reference

8 February 2018

publication date

20 June 2016

1 reference

8 February 2018

published in

Psychopharmacology

1 reference

8 February 2018

volume

233

1 reference

8 February 2018

issue

15-16

1 reference

8 February 2018

page(s)

3051-3059

1 reference

8 February 2018

What can we learn about depression from gene expression in peripheral tissues?

cites work

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Meta-Analysis of Cytokines and Chemokines in Suicidality: Distinguishing Suicidal Versus Nonsuicidal Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Augmentation strategies for treatment-resistant depression: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Applications of blood-based protein biomarker strategies in the study of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Statistical protein quantification and significance analysis in label-free LC-MS experiments with complex designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

From inflammation to sickness and depression: when the immune system subjugates the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Diagnosis and definition of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Mining the plasma proteome for cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

The inflammasome: pathways linking psychological stress, depression, and systemic illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Affinity depletion of plasma and serum for mass spectrometry-based proteome analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Selected reaction monitoring for quantitative proteomics: a tutorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

The role of inflammation in depression: from evolutionary imperative to modern treatment target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Psychiatric blood biomarkers: avoiding jumping to premature negative or positive conclusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Quality-of-life impairment in depressive and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Staging methods for treatment resistant depression. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Relationship between depression and apolipoproteins A and B: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

European Group for the Study of Resistant Depression (GSRD)--where have we gone so far: review of clinical and genetic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Estimating the Dimension of a Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Mass spectrometry-based proteomic quest for diabetes biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

A detailed examination of cytokine abnormalities in Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Inflammation and clinical response to treatment in depression: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Gene ontology: tool for the unification of biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Gene Ontology Consortium: going forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4348-0

Cytokine production and treatment response in major depressive disorder

21 January 2018

1 reference

12 December 2020

The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases.

1 reference

12 December 2020

A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method

1 reference

12 December 2020

Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation

1 reference

12 December 2020

Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy

1 reference

12 December 2020

Issues in treatment-resistant depression

1 reference

12 December 2020

When at first you don't succeed: sequential strategies for antidepressant nonresponders

1 reference

12 December 2020

Defining treatment-resistant depression: a comprehensive review of the literature.

1 reference

12 December 2020

Association of the COMT val158met variant with antidepressant treatment response in major depression

1 reference

12 December 2020

Serum proteomic profiling of major depressive disorder

1 reference

12 December 2020

Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond

1 reference

12 December 2020

Prevalence and management of treatment-resistant depression.

1 reference

12 December 2020

10.1007/S00213-016-4348-0

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018